JIH-HSIANG LEEANN-LII CHENGCHUNG-WU LINSUNG-HSIN KUO2020-03-032020-03-0320090007-0963https://www.scopus.com/inward/record.uri?eid=2-s2.0-62649139101&doi=10.1111%2fj.1365-2133.2009.09042.x&partnerID=40&md5=fcb7a3784a0ff1060e5edc256158b75fhttps://scholars.lib.ntu.edu.tw/handle/123456789/468892[SDGs]SDG2[SDGs]SDG3anaplastic lymphoma kinase; CD30 antigen; chlorambucil; gamma interferon; immunoglobulin enhancer binding protein; isotretinoin; prednisolone; thalidomide; tumor necrosis factor alpha; adult; article; cancer regression; cancer survival; case report; disease free survival; drug mechanism; erythema; female; histopathology; human; human tissue; immunohistochemistry; large cell lymphoma; male; priority journal; prognosis; protein expression; skin biopsy; skin nodule; treatment response; Antineoplastic Agents; Female; Humans; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Male; Middle Aged; NF-kappa B; Remission Induction; Skin Neoplasms; Thalidomidejournal article10.1111/j.1365-2133.2009.09042.x192224542-s2.0-62649139101